31st Oct 2022 15:23
(Sharecast News) - Intellectual property commercialisation company Allied Minds was in the green on Monday afternoon, after one of its non-executive directors bought almost half a million shares.
Read more24th Aug 2022 10:17
(Sharecast News) - Allied Minds shares tumbled on Wednesday after the company - which invests in the tech and life sciences sectors - said it was planning to delist from the London Stock Exchange.
Read more26th Sep 2019 12:42
(Sharecast News) - Intellectual property commercialisation company Allied Minds reported a fall in first-half net cash and investments to $56.8m (£45.04m) on Thursday, from $97.7m year-on-year, of which it said $46.6m was held at the parent level, compared to $50.6m.
Read more12th May 2019 16:39
(Sharecast News) - Metro Bank has been forced to reassure customers their money is safe, acting quickly to quash what it described as false rumours on social media about its financial health. It said plans to raise £350m from investors to shore up its finances were "well advanced".- The Guardian
Read more24th Sep 2018 11:05
(Sharecast News) - Allied Minds announced on Monday that its subsidiary, Spin Transfer Technologies, had appointed John Kispert as the independent chairman of its board of directors.
Read more18th Sep 2018 12:47
(Sharecast News) - Allied Minds announced the formation of new subsidiary 'QuayChain' on Tuesday.
Read more13th Dec 2016 07:34
(ShareCast News) - US science and technology developer Allied Minds is to form a new subsidiary, Signature Medical, to work with Boston University to develop a wearable device to monitor heart failure. Signature Medical has secured a worldwide option to license patent rights from the universit
Read more2nd Dec 2016 07:37
(ShareCast News) - Science and technology investor Allied Minds has raised £64m ($81m) in an equity placing to increase investment in its portfolio of businesses and fund a pipeline of emerging technologies. The FTSE 250 company, through broker Credit Suisse Securities, placed over 17.4m shares at 3
Read more23rd Nov 2016 08:06
(ShareCast News) - Allied Minds' subsidiary HawkEye 360 has raised $11m in new equity investment in a series A financing. The funds will be used to complete the development and manufacturing of the HawkEye 360 Pathfinder Cluster of three small satellites, which is due to launch and test late next ye
Read more21st Nov 2016 07:06
(ShareCast News) - US science and technology developer Allied Minds has created a new subsidiary Vatic Materials, which has agreed to license certain materials technologies from Pennsylvania State University. Vatic Materials is to focus on developing materials and fabrication processes for transpare
Read more24th Oct 2016 08:30
(ShareCast News) - Star UK fund manager Neil Woodford has bought £5m of new shares in Allied Minds subsidiary Precision Biopsy. Woodford Investment Management, which is already a substantial shareholder in FTSE 250-listed Allied Minds purchased 0.95m preference shares in Precision Biopsy. Having de
Read more29th Sep 2016 08:12
(ShareCast News) - FTSE 250 intellectual property company Allied Minds partnered with General Electric's venture capital subsidiary to commercialise next generation technologies. Allied Minds and GE Ventures agreed to invest in new and existing technologies from each of their innovation pipelines.
Read more25th Aug 2016 08:05
(ShareCast News) - Allied Minds, the university and government technology commercialisation specialist, reported an increased loss, smaller revenue and flat value of its investment assets over the first half of the year. However, the company remains more firmly focused on investing in its various as
Read more22nd Aug 2016 07:07
(ShareCast News) - Venture capital-style investor Allied Minds has arranged a one-year debt facility Silicon Valley Bank in the US, while its drug discovery subsidiary has raised funds for its leading project from institutional investors. Secured over certain group assets, the $20m one-year facility
Read more1st Aug 2016 08:12
(ShareCast News) - Life science and technology investor Allied Minds announced on Monday that one of its key subsidiaries, SciFluor Life Sciences, has achieved the necessary scientific and regulatory milestones to enter clinical trials. The FTSE 250 company said SciFluor's Investigational New Drug a
Read more